SWOT Analysis — Company Profile

Overview

Strengths** | **Weaknesses** | |---|---|---| | **Internal** | 1. Focused ART product specialisation creates deep clinical relationships with IVF laboratory directors and reproductive endocrinologists, a structural advantage over generalist competitors. CE-mark heritage and EU MDR compliance readiness provide a defensible regulatory moat in European markets, where compliance barriers are rising.

Table of Contents

• Company Overview & Strategy
• Financial Performance (2022–2024)
• Product Portfolio
• SWOT Analysis